Molecular cloning has established the structure of preprocholecystokinin in porcine cerebral cortex and duodenal mucosa. This precursor is 114 amino acids long, is identical in brain and gut, contains all the cholecystokinin (CCK) peptides previously isolated, and has the characteristics of a prohormone. It contains a putative amino-terminal signal peptide, basic processing sites, and a carboxyl-terminal amidation signal. The CCK mRNAs from brain and gut are =850 nucleotides long and differ by only a few single base changes. This analysis establishes by a strict criterion that CCK is synthesized in both brain and gut and that the different distributions of molecular forms of CCK in the two tissues are most probably a consequence of tissue-specific posttranslational events.
In 1966, Jorpes and Mutt purified a 33 amino acid peptide from pig gut that was active in the periphery in promoting contraction of the gallbladder and in stimulating secretion of pancreatic enzymes (1, 2) . Initially called cholecystokininpancreozymin, the peptide is now conventionally termed cholecystokinin (CCK). Vanderhaeghen et al. in 1975 identified a peptide in the vertebrate central nervous system that reacted with antibodies against gastrin (3) . Other groups showed that the crossreacting material belongs to the family of CCK peptides that share a common COOH-terminal pentapeptide with gastrin (4) (5) (6) (7) (8) . CCK is unique among brain-gut peptides in that its concentration in brain is comparable to that in the intestine. However, there has been no clear evidence that the CCK biosynthetic pathways in the two tissues are the same. Differences between CCK in brain and gut might even suggest otherwise, because distributions of molecular forms of CCK are very different in the two tissues (9) . Pig brain contains CCK-octapeptide (CCK8), several CCK-desoctapeptides, and no detectable intact CCK33, whereas pig gut contains intact CCK33, CCK39, and CCK58 as well as CCK-octapeptide and the CCK-desoctapeptides (10) . These differences could be due either to different posttranslational processing or to expression of different mRNAs coding for CCK in the two tissues. In an effort to resolve this question, we have isolated cDNA clones of CCK mRNA from both brain and gut. Sequencing of these cDNAs has allowed us to determine that the CCK precursors in both tissues are indeed the same.
MATERIALS AND METHODS
Solid-phase triester methodology (11) was used for the synthesis of a mixed oligodeoxynucleotide probe (Fig. 1 go(dT)-cellulose (12, 13) . Double-stranded cDNA was synthesized from total poly(A)+ RNA with oligo(dT)12_18 as the primer and cloned in Escherichia coli RRI as described (14, 15) . Specifically primed cDNA libraries were established as follows: 40 pmol of the synthetic oligonucleotide ( Fig. 1) were annealed to 10 pkg of methylmercury hydroxide-pretreated total poly(A)+ RNA (16) in 25 ,ul of 40 mM NaOAc/2 mM EDTA (5 min at 95°C, 10 min at 43°C, 10 min at 20°C).
Subsequent cDNA synthesis and cloning were as described (14, 15) . 32P-labeled oligonucleotide (17) was used for colony screening (18) at 0.25 pmol of probe per ml as described (19) . The filters were quickly rinsed in 0.6 M sodium chloride/0.06 M sodium citrate at room temperature, followed by a high-stringency wash in the same buffer at 42°C for 1 hr. Filters were then exposed to x-ray film overnight, using an intensifying screen. DNA sequencing, RNA blot analysis, nick-translation, primer extension, and denaturing agarose gel electrophoresis were performed according to standard procedures (17, (19) (20) (21) (22) (23) (24) . Cell-free translations and immunoprecipitations were as described (19) , with an antiserum that is specific for the NH2 terminus of porcine CCK33 (9 brain library and had inserts of 500 base pairs (bp) (no. 134), 480 bp (no. 136), and 750 bp (no. 148). The two clones from the gut library had inserts of 580 bp (no. 229) and 720 bp (no. 230). Partial sequencing using the chain terminator method (20) and the specific oligonucleotide as a primer confirmed the presence of sequences coding for CCK peptides. The inserts of four clones (nos. 134, 148, 229, and 230) were then completely sequenced by using the chemical sequencing method (17) . In an attempt to clone cDNA sequences representing the very 5' portions of the CCK mRNAs, we established two additional libraries. To enrich for CCK cDNA clones, the oligonucleotide described in Fig. 1 Table 1 are indicated by x. The presumed polyadenylylation sequence A-U-U-A-A-A is underlined. The putative signal peptide is underlined (amino acid residues [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 
A C C A C t All clones listed were generated by priming the cDNA synthesis with oligo(dT)12_18 and therefore contained the full 3'-untranslated region of the mRNA. Two specifically primed clones, no. 178 for brain and no. 240 for gut, contained a C at position 242. See Fig. 2 for nucleotide sequences. *Position 242 is in the coding region. clones is shown in Fig. 2 . The mRNA sequences from brain and gut as determined by sequencing their cDNAs encode all of the known molecular forms of CCK. In addition, the structure of a CCK precursor (preproCCK) can be deduced from the cDNA sequences. This precursor is identical in both brain and gut. It is 114 amino acids long (predicted Mr = 12,600) and has all of the typical characteristics of a prohormone (see Discussion).
In vitro translation of total poly(A)+ RNA from both tissues followed by CCK-specific immunoprecipitation demonstrated that the preproCCK is indeed identical in size in brain and gut (data not shown). The experimentally determined Mr for preproCCK from this analysis was =15,000, a value that agrees reasonably well with the prediction from the cDNA sequence of Mr = 12,600.
The CCK mRNA sequences from brain and gut differ in only a few nucleotides ( Table 1) . One of these differences is located in the coding region in the third position of codon no. 62. It does not change the amino acid sequence. All of the other differences are confined to the 3'-untranslated region of the mRNAs (Fig. 2) ferences according to tissue. Since the tissue samples used to isolate the template poly(A)+ RNA originated from several animals, the differences may be accounted for by allelic variations. A hexanucleotide sequence, A-U-U-A-A-A (Fig.  2) , very similar to the canonical A-A-U-A-A-A polyadenylylation signal (25) , can be found 15 nucleotides upstream from the poly(A) tail. Modifications of the A-A-U-A-A-A sequence have been reported (26) .
The size of the CCK mRNAs in both tissues was estimated by RNA blot analysis (Fig. 3) . Both mRNAs are -850 nucleotides long. Primer extension experiments (Fig. 4) have consistently shown two major extension products, 153 nucleotides and 282 nucleotides long. The shorter product is only a few nucleotides longer than the sequence shown in Fig. 2 . The size of the longer extension product indicates that the cloned sequences (670 bp, Fig. 2 ) are missing -130 nucleotides from the 5' ends of the mRNAs. This is in good agreement with the size of the mRNAs as determined by RNA blot analysis.
DISCUSSION
Molecular cloning of CCK mRNA from porcine cerebral cortex and duodenal mucosa has allowed us to determine that CCK is synthesized as an identical precursor protein in both tissues. Sequencing of a total of six independent cDNA clones demonstrated that the mRNA sequences from both tissues differ only in a few nucleotides. None of these changes results in changes in the deduced amino acid sequence of preproCCK. Translational initiation was assigned to the first AUG triplet within the deduced mRNA sequence. The sequence of the 20 amino acids following that methionine fulfills all of the standard criteria for a signal peptide: it is rich in hydrophobic amino acids and ends in alanine, a residue with a small neutral side chain (27) . Thus, preproCCK is probably 114 amino acids long (calculated Mr = 12,600) and contains all of the known molecular forms of CCK. Agreement with the predicted molecular weight, identity in size, and immunological similarity of preproCCK from both tissues was also demonstrated by in vitro translation of total brain or gut poly(A)+ RNA. All of these findings strongly suggest that the differences found in the distribution of molecular forms of CCK in brain and gut are due to tissuespecific posttranslational processing events and not to the fact that there are two different genes being expressed. The proform of CCK shows additional characteristic features of prohormones (27) . There are three double basic processing signals, all of which are candidate sites for cleavage. In contrast, only a subset of the rather unusual monobasic processing sites is recognized and cleaved to generate some of the smaller CCK peptides. The COOH-terminal phenylalanine of CCK8 is amidated in vivo. Consistent with this amidation is the finding of the COOH-terminal sequence Gly-Arg-Arg immediately following the phenylalanine in the primary translation product (28) .
The size of the CCK mRNA was determined by RNA blot analysis. It was found to be identical in both brain and gut, -850 nucleotides. Several attempts to either clone or directly sequence the longest extension product shown in Fig. 4 were all unsuccessful. Thus, it is still possible that the CCK mRNAs from brain and gut differ at the very 5' ends.
Recently, the mRNA for rat preproCCK has been cloned and sequenced from a medullary thyroid carcinoma (29) . The tumor had been shown to contain about 20-to 40-fold higher concentrations of immunoreactive CCK8 than brain. A comparison between rat and pig CCK shows that the preproforms from both species are very similar (Fig. 5) . Most of the extensive homologies occur in the COOH-terminal half of the molecules that contain the CCK peptides that have been purified. The overall homology of the precursors is 74% (mRNAs = 68%).
The mammalian intestinal hormone gastrin and the frog skin decapeptide caerulein both contain a COOH-terminally amidated pentapeptide sequence Gly-Trp-Met-Asp-Phe-NH2 that is identical in CCK8 (4) (5) (6) (7) (8) 31 (30) . Mismatches and deletions or loopouts necessary for maximizing homologies are marked with an asterisk. levels in different brain and gut regions will complement the measurements of CCK peptide levels that have already been made. Finally, the clones should allow the study of the genomic structure of porcine CCK as well as the isolation of human CCK mRNAs.
